Journal Publications
Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
Author(s) |
Date | Article Title | Journal |
|---|---|---|---|
|
Sebastian Pölsterl, Pankaj Gupta, Lichao Wang, Sailesh Conjeti, Amin Katouzian, Nassir Navab |
July 2017 | Heterogeneous ensembles for predicting survival of metastatic, castrate-resistant prostate cancer patients | F1000 Research |
|
Shalhout, Sophia Z.; Kaufman, Howard L.; Sullivan, Ryan J.; Lawrence, Donald; Miller, David M. |
June 2021 | Immune Checkpoint Inhibition in Marjolin Ulcer: A Case Series | Journal of Immunotherapy |
|
Shiyu Jiang, Liling Huang, Hongnan Zhen, Peijie Jin, Jing Wang & Zhihuang Hu |
December 2021 | Carboplatin versus cisplatin in combination with etoposide in the first-line treatment of small cell lung cancer: a pooled analysis | BMC Cancer |
|
Siddharth Ramchandran, Gleb Tikhonov, Otto Lönnroth, Pekka Tiikkainen, Harri Lähdesmäki |
March 2022 | Learning Conditional Variational Autoencoders with Missing Covariates | arXiv |
|
Sophia Z Shalhout, Farees Saqlain, Kayla Wright, Oladayo Akinyemi, David M Miller |
January 2022 | Generalizable EHR-R-REDCap pipeline for a national multi-institutional rare tumor patient registry | Jamia Open |
|
Sophia Z. Shalhout, Kevin S. Emerick, Howard E. Kaufman, David M. Miller |
June 2022 | A retrospective study of ipilimumab plus nivolumab in anti–PD-L1/PD-1-refractory merkel cell carcinoma | Journal of Clinical Oncology |
|
Sophia Z. Shalhout, Kevin S. Emerick, Peter M. Sadow, Jenny J. Linnoila, David M. Miller |
September 2020 | Regionally Metastatic Merkel Cell Carcinoma Associated with Paraneoplastic Anti-N-methyl-D-aspartate Receptor Encephalitis | Case Reports in Oncological Medicine |
|
Sophia Z. Shalhout, Kevin S. Emerick, Peter M. Sadow, Jenny J. Linnoila, David M. Miller |
September 2020 | Regionally Metastatic Merkel Cell Carcinoma Associated with Paraneoplastic Anti-N-methyl-D-aspartate Receptor Encephalitis | Case Reports in Oncological Medicine |
|
Sophia Z.Shalhout, PhD; Jong ChulPark, MD; Kevin S.Emerick,MD; Ryan J.Sullivan, MD; Howard L.Kaufman, MD; David M.MillerMD, PhD |
January 2021 | Real-world assessment of response to anti-PD-1 therapy in advanced cutaneous squamous cell carcinoma | Journal of the American Academy of Dermatology |
|
Soren Wengel Mogensen, Anne H. Petersen, Ann-Sophie Buchardt, Niels Richard Hansen |
November 2017 | Survival prognosis and variable selection: A case study for metastatic castrate resistant prostate cancer patients | F1000 Research |
|
Steffen Ventz, PhD, Leah Comment, PhD, Bill Louv, PhD, Rifaquat Rahman, MD, Patrick Y Wen, MD, Brian M Alexander, MD, Lorenzo Trippa, PhD |
June 2021 | The Use of External Control Data for Predictions and Futility Interim Analyses in Clinical Trials | Neuro-Oncology |
|
Steffen Ventz, Sean Khozin, Bill Louv, Jacob Sands, Patrick Y. Wen, Leah Comment, Brian M. Alexander, Lorenzo Trippa |
March 2022 | The Design and Evaluation of Hybrid Controlled Trials that Leverage External Data and Randomization | Research Square |
|
Steven B.Cohen, Jennifer Unangst, Feng Yu |
November 2020 | Enhancing the analytic utility of clinical trial data to inform health disparities research | Contemporary Clinical Trials Communications |
|
T.Elumalai, C.Barker, T.Elliott, J.Malik, A.Tran, A.Hudson, Y.P.Song, K.Patel, J.Lyons, P.Hoskin, A.Choudhury, H.Mistry |
March 2022 | Translation of Prognostic and Pharmacodynamic Biomarkers from Trial to Non-trial Patients with Metastatic Castration-resistant Prostate Cancer Treated with Docetaxel | Clinical Oncology |
